Back to News
Sep 29, 2025 8:00 AM

4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week technical strength and strong price action.

Spotlight On 4 Biotech Stocks

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR), Assembly Biosciences Inc. (NASDAQ: ASMB), Atara Biotherapeutics Inc. (NASDAQ: ATRA), and Corcept Therapeutics Inc.‘s (NASDAQ: CORT) momentum percentile jumps make them stand out in the healthcare sector, particularly within the highly competitive biotech space.

What Does Momentum Ranking Mean?

Momentum percentile, as defined by Benzinga Edge’s Stock Ranking, measures a stock's relative strength and recent price performance compared to its peers. A rapid rise in this ranking indicates increasing investor interest and robust technical behavior.

Arrowhead Pharmaceuticals

ARWR momentum percentile soared from 89.87 to the 93.79th percentile, delivering a week-on-week gain of 3.92 percentage points. This underscores exceptionally strong price action, positioning the stock ahead of most biotech rivals in terms of recent performance.

The stock has risen by 66.92% year-to-date and 69.33% over a year.

It maintains a stronger price trend over the short, medium, and long term. Additional performance details are available here.